Quotient Bioresearch Announces Webinar Series

Quotient Bioresearch has announced an educational webinar series entitled "14C Enabled Drug Development in Pharmaceutical R&D."

The webinars will consist of scientific presentations from industry experts focused on a range of drug development activities that can be enhanced by 14C radiolabelled studies.

The webinar series begins April 27 and runs during May and early June 2010. Each of the four webinars will cover specific topics: Metabolism; Species and Interspecies Dependent Metabolism; ivPK and Absolute Bioavailability; and Quotient's new Synthesis-to-Clinic platform. All four webinars are free of charge to attend and will also be available to view on demand after the event.